Biotech · Private company
Rapamycin Holdings Inc.
Track this companyFree. Adds Rapamycin Holdings Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- eRapa (encapsulated rapamycin)Phase 3 · Familial Adenomatous Polyposis (FAP)ClinicalTrials.gov · fetched Nov 12, 2026
- Encapsulated Rapamycin (eRapa)Phase 2 · Familial Adenomatous PolyposisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Phase 3 Trial of eRapa in Patients With Familial Adenomatous PolyposisPHASE3 · RECRUITING · started Jul 18, 2025ClinicalTrials.gov NCT06950385 · fetched Nov 12, 2026
- Trial of eRapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active SurveillancePHASE2 · COMPLETED · started Jan 18, 2021ClinicalTrials.gov NCT04230499 · fetched Nov 12, 2026